Article Details

Pfizer selects once-daily GLP-1 for its obesity push - Pharmaphorum

Retrieved on: 2024-07-12 20:13:39

Tags for this article:

Click the tags to see associated articles and topics

Pfizer selects once-daily GLP-1 for its obesity push - Pharmaphorum. View article details on hiswai:

Excerpt

Pfizer's push into obesity will be led by a once-daily formulation of GLP-1 agonist danuglipron as it tries to catch up with Novo Nordisk and Eli ...

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up